Site Search
Results
-
NAEHSC Meeting Minutes February 2021
... However, if you identified an epigenetic predictor of future disease risk, there are potential interventions, such as epigenetic therapies for certain types of diseases. Dr. Hertz- ...
Size: 257KB https://www.niehs.nih.gov/sites/default/files/about/assets/docs/february_2022_minutes_508.pdf -
DIR NAEHS Council Update February 2018
... cellular and molecular mechanisms triggered by these various agents is poorly understood, but it might explain the differential responsiveness of patients to specific therapies. ...
Size: 262KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/feb2020/report_from_division_of_intramural_research_feb_12_508.pdf -
Division of Intramural Research - NAEHS Council Update - September 2009
... Exposed in utero to AZT AZT based therapies during pregnancy have proven very ... the consequence of anti- HIV therapy to newborns exposed in utero to these therapies. ...
Size: 301KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2010/report_of_the_division_of_intramural_research_508.pdf -
FEATURED ACTIVITIES of DERT May 2011
... Dr. Tyson chaired the session entitled, Epigenetic Therapies in the Clinic (Human Studies). It focused on the use of epigenetics in drug discovery and the use of HDAC (histone ...
Size: 548KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2011/may2011staffactivities_508.pdf -
Division of Intramural Research - NAEHS Council Update
... Exposed in utero to AZT AZT based therapies during pregnancy have proven very ... the consequence of anti- HIV therapy to newborns exposed in utero to these therapies. ...
Size: 297KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2009/report_of_the_division_of_intramural_research_508.pdf -
Featured Activites of DERT - October 2009
... Traditional cancer therapies cure many squamous cell carcinomas, but a significant proportion of patients go on to develop a second primary malignancy. GSTs are known to detoxify ...
Size: 222KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2009/report_on_the_featured_activities_of_the_division_of_extramural_research_and_training_508.pdf -
Featured Activities of DERT
... methyl mercury exposure. These findings could be important in the identification and development of therapies to reduce methyl mercury-induced damage to the central nervous system. ...
Size: 252KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2011/featured_activities_of_dert_october_2011_508.pdf -
Sep12 NAEHS Council Update DIR
... system by defending the body from infection and are being exploited in cancer therapies. ... and responsiveness of individual TLRs should be considered in TLR-based cancer therapies. ...
Size: 466KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2012/naehs_dir_report_508.pdf -
DIR NAEHS Council Update, September 2013
... glucocorticoid/GPCR agonist combination therapies currently used to treat asthma and ... to prime activation by other treatments to provide more effective combined therapies. ...
Size: 309KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2013/dir_report_508.pdf -
Sept 16 NAEHS Council Update
... candidate for the development of new therapies for these and related conditions in man. ... that is prolonged beyond two years, often lasting many years despite adequate therapies. ...
Size: 286KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2016/sept_report_from_division_of_intramural_research_508.pdf
to Top